Syndopa side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Accelerated hypertension (significant hypertension)
2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
3. Coma (state of unconsciousness lasting more than six hours)
4. Respiratory disorder (respiratory disease)

male:

1. Anxiety
2. Cardiac arrest
3. Renal failure (kidney dysfunction)
4. Urinary tract infection
5. Decreased appetite
6. Abdominal pain
7. Death
8. Anaemia (lack of blood)
9. Central nervous system infection (infection of brain or spinal cord)
10. Device dislocation

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

1. Abdominal pain

40-49:

1. Anxiety

50-59:

n/a

60+:

1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
2. Central nervous system infection (infection of brain or spinal cord)
3. Coma (state of unconsciousness lasting more than six hours)
4. Device dislocation
5. Drug ineffective
6. Pyrexia (fever)
7. Renal failure (kidney dysfunction)
8. Respiratory disorder (respiratory disease)
9. Urinary tract infection
10. Cardiac arrest

< 1 month:

n/a

1 - 6 months:

1. Anxiety

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Cardiac arrest
2. Central nervous system infection (infection of brain or spinal cord)
3. Chills (felling of cold)
4. Coma (state of unconsciousness lasting more than six hours)
5. Device dislocation
6. Drug ineffective
7. Pyrexia (fever)
8. Renal failure (kidney dysfunction)
9. Respiratory disorder (respiratory disease)
10. Urinary tract infection